Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Loss of Nogo-A, encoded by the schizophrenia risk gene Rtn4, reduces mGlu3 expression and causes hyperexcitability in hippocampal CA3 circuits.
|
30040841 |
2018 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The TATC and CAA insertion/deletion polymorphisms of RTN4 3'-UTR have been linked to schizophrenia, depression, and dilated cardiomyopathy.
|
22320844 |
2012 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Allelic tests showed nominally significant association of two RTN4 SNPs (P = 0.047 and 0.037 for rs11894868 and rs2968804, respectively) and two MAG SNPs (P = 0.034 and 0.029 for rs7249617 and rs16970218, respectively) with schizophrenia.
|
21563301 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
CTD_human |
Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes.
|
20071518 |
2010 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia.
|
19165527 |
2009 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The TATC and CAA 3'UTR insertion/deletion polymorphisms of the RTN4, the gene encoding Nogo isoforms A, B and C, have been linked to schizophrenia and depression, but data were inconsistent.
|
18948092 |
2009 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Nogo A, B and C expression in schizophrenia, depression and bipolar frontal cortex, and correlation of Nogo expression with CAA/TATC polymorphism in 3'-UTR.
|
17022955 |
2006 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia.
|
15661375 |
2005 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
The Nogo gene maps to 2p14-p13, a region consistently associated with schizophrenia and bipolar disorder.
|
15820318 |
2005 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Novak et al.[Brain Res.Mol.Brain Res.107 (2002) 183] reported that a CAA insertion in the 3'-untranslated region of the Nogo gene was associated with schizophrenia.
|
14741411 |
2004 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our current data suggest that the genetic polymorphisms within RTN4 are unlikely to confer an increased susceptibility to schizophrenia in the Chinese population.
|
15234466 |
2004 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
LHGDN |
Because the 3'-untranslated regions of eukaryotic genes are known to regulate gene expression, the increased frequency of the Nogo CAA insert in schizophrenia may contribute to abnormal regulation of Nogo gene expression, and may indicate a role for Nogo in disturbed neurodevelopment in schizophrenia.
|
12425946 |
2002 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Because the 3'-untranslated regions of eukaryotic genes are known to regulate gene expression, the increased frequency of the Nogo CAA insert in schizophrenia may contribute to abnormal regulation of Nogo gene expression, and may indicate a role for Nogo in disturbed neurodevelopment in schizophrenia.
|
12425946 |
2002 |
Colorectal Carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
While little is known about the role of RTN4 in colorectal cancer, this protein has been established as a critical mediator of endoplasmic reticulum tubular network formation.
|
28352901 |
2017 |
Colorectal Carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
These results indicate that RTN4-C has an important role in colorectal cancer cell growth, which may provide a potential therapeutic approach for human colorectal cancer.
|
25847052 |
2015 |
Colorectal Carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
International comparisons show strong inverse protective associations with starch, NSP (fibre, non-starch polysaccharides) and vegetable intakes, and positive associations with meat consumption in large bowel cancer.
|
9103247 |
1997 |
Colorectal Carcinoma
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Bipolar Disorder
|
0.310 |
Biomarker
|
disease |
BEFREE |
The Nogo gene maps to 2p14-p13, a region consistently associated with schizophrenia and bipolar disorder.
|
15820318 |
2005 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Visual seizure
|
0.200 |
Biomarker
|
disease |
RGD |
Hippocampal Nogo-A and neo-Timm's staining in amygdala kindling rats.
|
17439704 |
2007 |
Hepatitis C
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Impact of IFNL4 Genetic Variants on Sustained Virologic Response and Viremia in Hepatitis C Virus Genotype 3 Patients.
|
31260374 |
2019 |
Hepatitis C
|
0.110 |
Biomarker
|
disease |
BEFREE |
The Australian NSP Survey (ANSPS), conducted annually at ∼50 NSP services across Australia, consists of a brief self-administered questionnaire and provision of a capillary dried blood spot for HIV and hepatitis C antibody testing.
|
28104570 |
2017 |
Red cell distribution width determination
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Finding of Mean Corpuscular Hemoglobin
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
RDW - Red blood cell distribution width result
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |